Electrochemical evidence of nitrate release from the nitrooxy compound 4-((nitrooxy) methyl)-3-nitrobenzoic acid and its antinociceptive and anti-inflammatory activities in mice

• Main Authors: Alysson Vinícius Braga, Roger Ryuler Lisboa da Silva, Ianny Bandeira Rodrigues, Gabriel Vitor de Lima Marques, Andre Felippe de Almeida Xavier, Anastacio Boane, Mayara Rodrigues Brandão de Paiva, Pedro Henrique Cavalcanti Franco, Felipe Fernandes Rodrigues, Ivo Souza Ferraz Melo, Armando da Silva Cunha Júnior, Isabela da Costa César, Marília Oliveira Fonseca Goulart, Renata Barbosa de Oliveira, Márcio de Matos Coelho, Renes Resende Machado
• Format: Article
• Language: English
• Published: Elsevier 2021-01-01
• Series: Biomedicine & Pharmacotherapy
• Subjects: 4-((Nitrooxy) methyl)-3-nitrobenzoic acid; Nitric oxide; Nitrate; Pain; Inflammation; Cytokines
• Online Access: http://www.sciencedirect.com/science/article/pii/S0753332220311057

Considering the many biological activities of nitric oxide (NO), some lines of research focused on the modulation of these activities through the provision of this mediator by designing and synthesizing compounds coupled with an NO donor group. Thus, the objectives of the present study were to carry out an electrochemical investigation of the nitrooxy compound 4-((nitrooxy) methyl)-3-nitrobenzoic acid (1) and evaluate its activities and putative mechanisms in experimental models of pain and inflammation. Voltammetric studies performed in aprotic medium (mimetic of membranes) showed important electrochemical reduction mechanisms: nitroaromatic reduction, self-protonation, and finally reductive elimination, which leads to nitrate release. Systemic administration of the nitrooxy compound (1) inhibited the nociceptive response induced by heat and the tactile hypersensitivity and paw edema induced by carrageenan in mice. The activities in the models of inflammatory pain and edema were associated with reduced neutrophil recruitment and production of inflammatory cytokines, such as interleukin (IL)-1β, IL-6, tumor necrosis factor-α and CXCL-1, and increased production of IL-10. Concluding, electrochemical analysis revealed unequivocally that electron transfer at the nitro group of the nitrooxy compound (1) results in the cleavage of the organic nitrate, potentially resulting in the generation of NO. This electrochemical mechanism may be compared to a biochemical electron-transfer mediated nitrate release that, by appropriate in vivo bioreduction (enzymatic or not) would lead to NO production. Compound (1) exhibits activities in models of inflammatory pain and edema that may be due to reduced recruitment of neutrophils and production of inflammatory cytokines and increased production of IL-10. These results reinforce the interest in the investigation of NO donor compounds as candidates for analgesic and anti-inflammatory drugs.